Letters to the Editor

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Winship Cancer Institute of Emory University, Atlanta, GA
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
University of Chicago, Chicago, IL
University of Chicago, Chicago, IL
University of Texas Southwestern Medical Center, Dallas, TX
University of Texas Southwestern Medical Center, Dallas, TX
Memorial Sloan Kettering Cancer Center, New York, NY
Division of Hematology/Oncology and Rogel Cancer Center, University of Michigan, Ann Arbor, MI
David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
University of Colorado Anschutz Medical Campus, Aurora, CO
Mayo Clinic, Jacksonville, FL
University of California, San Francisco, San Francisco, CA
University of Kansas Medical Center, Kansas City, KS
University of Pittsburg Hillman Cancer Center, Pittsburgh, PA
The Ohio State University, Columbus, OH
Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT
Biopharmatech Consulting Inc., Leesburg, VA
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
The Ohio State University, Columbus, OH
Blood Cancer United, Washington, DC
Blood Cancer United, Washington, DC
Knight Cancer Institute, Oregon Health and Science University, Portland, OR
Memorial Sloan Kettering Cancer Center, New York, NY
Blood Cancer United, Washington, DC
Blood Cancer United, Washington, DC
University of Cincinnati, Cincinnati, OH
Winship Cancer Institute of Emory University, Atlanta, GA
Haematologica Early view Apr 23, 2026 https://doi.org/10.3324/haematol.2026.300627